You are here

  • Zarin D. Participant-level data and the new frontier in trial transparency. N Engl J Med. 2013 Aug 1;369(5):468-9. doi: 10.1056/NEJMe1307268.
  • Zarin D, Tse T. Clarification about ClinicalTrials.gov. IRB. 2013 May-Jun;35(3):19.
  • Zarin DA, Tse T. Unambiguous identification of obesity trials. N Engl J Med. 2013 Feb 7;368(6):580-1. doi: 10.1056/NEJMc1215018.
  • Zarin D. Factual Errors about ClinicalTrials.gov and other federal mandates in special report by Shuster. Clin Transl Sci. 2012 Apr;5(2):217; author reply 217. doi: 10.1111/j.1752-8062.2012.00410.x.
  • Zarin D, Tse T. The effect of funding source on outcome reporting among drug trials. Ann Intern Med. 2011 Jan 18;154(2):137-8; author reply 138. doi: 10.7326/0003-4819-154-2-201101180-00020.